Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
about
Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young InfantsEvaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonatesSafety Concerns Surrounding Quinolone Use in Children.The amikacin research program: a stepwise approach to validate dosing regimens in neonates.Antimicrobial dosing in neonates.Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.Levofloxacin Use in the Neonate: A Case Series.Population pharmacokinetics and dosing optimisation of ceftazidime in infants.Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants.Advances in Pediatric Pharmacology, Therapeutics, and Toxicology.
P2860
Q35846147-D3F3BF5D-28F8-4940-B544-27A8DADEB1B4Q36243693-665AB98D-C5E2-41BB-A818-8C52C97FD0C7Q36924737-76A9C859-A1BF-41BC-8984-B440CCED4AA1Q37358644-C555AACA-D677-493E-A1EE-5E7F4F74C77DQ38657914-F25E7CFD-5BB8-4450-AE4F-F3A874E96077Q38728987-433256D0-8057-42C3-9F7F-C1740BC22676Q38821699-D94FCA6D-F7F5-48C8-8026-3558F8646255Q40380011-408C01CE-14CD-4E10-A022-4692B0CDB652Q40848375-6BCA0E60-3792-47BE-9DDB-99F2F9A9C2FBQ41455427-89679B3C-4701-4F92-9E9D-0120AA195795Q47645055-1F332936-886E-4C5A-B39E-11E4B039D9C1Q50044338-8F7EBB3B-0182-43D4-91A0-2D8622F9D8C2Q54194778-D3E829E2-4A81-4E25-BB18-36F2B3E55DFD
P2860
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Population pharmacokinetics of ...... less than three months of age.
@ast
Population pharmacokinetics of ...... less than three months of age.
@en
Population pharmacokinetics of ...... less than three months of age.
@nl
type
label
Population pharmacokinetics of ...... less than three months of age.
@ast
Population pharmacokinetics of ...... less than three months of age.
@en
Population pharmacokinetics of ...... less than three months of age.
@nl
prefLabel
Population pharmacokinetics of ...... less than three months of age.
@ast
Population pharmacokinetics of ...... less than three months of age.
@en
Population pharmacokinetics of ...... less than three months of age.
@nl
P2093
P2860
P50
P356
P1476
Population pharmacokinetics of ...... less than three months of age
@en
P2093
Chantal Le Guellec
Charlotte Castellan
Gregory L Kearns
Helen Hill
Johannes N van den Anker
Mark A Turner
Sarah Mahoney
TINN Consortium
P2860
P304
P356
10.1128/AAC.03568-14
P407
P577
2014-08-25T00:00:00Z